Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice
- 3 June 2015
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 241 (2), 313-321
- https://doi.org/10.1016/j.atherosclerosis.2015.05.020
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Thioredoxin interacting protein genetic variation is associated with diabetes and hypertension in the Brazilian general populationAtherosclerosis, 2012
- Thioredoxin Interacting Protein Promotes Endothelial Cell Inflammation in Response to Disturbed Flow by Increasing Leukocyte Adhesion and Repressing Kruppel-Like Factor 2Circulation Research, 2012
- Runx2-Upregulated Receptor Activator of Nuclear Factor κB Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Diminished AMPK signaling response to fasting in thioredoxin-interacting protein knockout miceFEBS Letters, 2011
- Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicityBritish Journal of Pharmacology, 2011
- Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Oxidized Phospholipids Induce Type VIII Collagen Expression and Vascular Smooth Muscle Cell MigrationCirculation Research, 2009
- Thioredoxin‐interacting protein deficiency induces Akt/Bcl‐xL signaling and pancreatic beta‐cell mass and protects against diabetesThe FASEB Journal, 2008
- Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT SignalingJournal of Biological Chemistry, 2008
- Txnip balances metabolic and growth signaling via PTEN disulfide reductionProceedings of the National Academy of Sciences of the United States of America, 2008